CISD2 and lung carcinoma: In this study, using a combined approach relating evidence from analysis of public gene expression data derived from clinical specimens of lung cancer tissues, cell-based assays, and animal xenograft models, we have identified the oncogenic properties of CISD2 and its clinical significance in lung ADC.